FDA reinstates generic drug policy group let go in April firings
The FDA has reinstated a generic drug policy team that was laid off in April, one that was at least partially responsible for leading the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
